Piramal Pharma - Quaterly Results

03 Aug 2023 Evaluate
The company witnessed a 13.39% growth in the revenue at Rs. 8464.30 millions for the quarter ended June 2023 as compared to Rs. 7464.70 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -333.60 millions as compared to Net Loss of Rs. -171.20 millions of corresponding quarter ended June 2022The company reported a good operating profit of 432.70 millions compared to 404.90 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 8464.30 7464.70 13.39 8464.30 7464.70 13.39 34432.20 33404.20 3.08
Other Income 266.80 1066.10 -74.97 266.80 1066.10 -74.97 3410.70 2247.90 51.73
PBIDT 432.70 404.90 6.87 432.70 404.90 6.87 4386.00 7000.70 -37.35
Interest 338.00 203.10 66.42 338.00 203.10 66.42 1158.70 572.90 102.25
PBDT 94.70 201.80 -53.07 94.70 201.80 -53.07 3157.70 6277.00 -49.69
Depreciation 503.70 447.80 12.48 503.70 447.80 12.48 1920.80 1653.70 16.15
PBT -409.00 -246.00 66.26 -409.00 -246.00 66.26 1236.90 4623.30 -73.25
TAX -75.40 -74.80 0.80 -75.40 -74.80 0.80 541.90 947.90 -42.83
Deferred Tax -75.40 -74.80 0.80 -75.40 -74.80 0.80 154.20 -160.30 -196.19
PAT -333.60 -171.20 94.86 -333.60 -171.20 94.86 695.00 3675.40 -81.09
Equity 11933.20 11859.10 0.62 11933.20 11859.10 0.62 11933.20 11859.10 0.62
PBIDTM(%) 5.11 5.42 -5.75 5.11 5.42 -5.75 12.74 20.96 -39.22

Piramal Pharma Share Price

252.60 -9.00 (-3.44%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.